通过一流的药物发现服务优化您的工作流程
高效的药物发现需要强大且完全集成的数据源。借助 CAS 解决方案（包括新的 CAS BioFinder Discovery Platform™），您可以按前所未有的速度解锁更深入的见解。
订阅生命科学时事通讯
Address critical risks at every stage of drug discovery
From target validation to lead optimization, our solutions work together to streamline drug discovery while minimizing risk.
Identify high-value targets by exploring curated disease, biomarker, and protein information with CAS BioFinder.
Learn more about CAS BioFinder
Refine leads with SAR insights, predictive bioactivity models, and MMPA visualizations using CAS BioFinder.
Learn more about CAS BioFinder
Break down your data silos and reveal pipeline insights by partnering with data experts through CAS Custom Services.
Learn more about CAS Custom Services
Develop synthesis plans and find suppliers that meet your needs with CAS SciFinder.
Learn more about CAS SciFinderStop making critical decisions with incomplete information
Drug discovery requires comprehensive biological, clinical, toxicological, and chemical data in one place. CAS unifies the key insights your team needs to innovate quickly.
- Unify cross-functional data from chemistry, biology, and clinical research into one connected environment.
- Enable flexible discovery with AI-ready data that integrates seamlessly into your analytics and workflows.
- Minimize guesswork with trustworthy insights powered by the CAS Content Collection™.
See how our life sciences data is built for your team’s success.
The current state of drug discovery: Is there a better way forward?
Time constraints force drug discovery scientists to choose between thoroughness and speed. Our white paper examines how teams are overcoming these challenges to innovate better and faster.
Frequently asked questions
How does CAS support the drug discovery workflow?
What ROI can I expect from using CAS BioFinder in my drug discovery workflow?
Can CAS BioFinder reduce the risk of late-stage drug failure?
How does CAS help with drug discovery R&D?
Related articles
Is your pharmaceutical product development taking too long?
